Investor's Business Daily |
Lilly Could Grab Diabetes Share From Dow's J&J On Amputation Woes
Investor's Business Daily Eli Lilly's (LLY) Jardiance will likely benefit most after the Food and Drug Administration required Dow component Johnson & Johnson (JNJ) to warn patients of leg and foot amputations associated with diabetes drug Invokana, an analyst said Tuesday. Johnson & Johnson (JNJ) |
Social Plugin